A media briefing from experts from the Infectious Diseases Society of America to discuss health disparities and inequities perpetuated by the COVID-19 pandemic:
- COVID’s disproportionate impact on historically underserved communities
- A science and equity-based framework for evaluating COVID-19 treatments
- What’s needed for equity in vaccine, testing, and clinical trials access
- Questions from media
FEATURED:
Allison L. Agwu, MD ScM FAAP FIDSA—Johns Hopkins University School of Medicine
Fellow—Infectious Diseases Society of America
Vice Chair—HIV Medicine Association
Professor, Pediatric and Adult Infectious Diseases, Johns Hopkins University School of Medicine
Co-Clinical Research Site Leader, JHU Adult AID Clinical Trials Group Unit
Emily Spivak, MD MHS FIDSA—University of Utah and VA Healthcare System
Fellow—Infectious Diseases Society of America
Chair – IDSA’s Antimicrobial Resistance Committee
Associate Professor, Division of Infectious Diseases, University of Utah Health
Co-director, Antimicrobial Stewardship Program, University of Utah Health and Salt Lake City VA Healthcare System
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
